AMSACRINE for Haematological malignancy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 6 adverse event reports in the FDA FAERS database where AMSACRINE was used for Haematological malignancy.

Most Reported Side Effects for AMSACRINE

Side Effect	Reports	%	Deaths	Hosp.
Off label use	47	10.3%	14	27
Death	46	10.1%	46	1
Septic shock	41	9.0%	34	16
Multiple organ dysfunction syndrome	40	8.8%	32	23
Acute myeloid leukaemia recurrent	39	8.5%	34	2
Venoocclusive liver disease	36	7.9%	12	19
Drug ineffective	35	7.7%	16	13
Febrile neutropenia	33	7.2%	0	20
Graft versus host disease	33	7.2%	21	18
Neutropenia	32	7.0%	22	20
Drug resistance	30	6.6%	8	19
Gastrointestinal disorder	28	6.1%	14	13
Bronchopulmonary aspergillosis	27	5.9%	8	9
Graft versus host disease in gastrointestinal tract	26	5.7%	14	15
Product use in unapproved indication	25	5.5%	9	5